Entdoc, I see these retrospective studies to be supporting of the MOA Thorpe has put forth for the switching of M2-type macrophages to M1-type, and that this could be a possible explanation for the increased survival seen in the NSCLC and possibly pancreatic cancer trials. I expect this would apply to breast and prostate cancers also.